Is smaller better? Vaccine targeting recombinant receptor-binding domain might hold the key for mass production of effective prophylactics to fight the COVID-19 pandemic

Signal Transduct Target Ther. 2020 Oct 6;5(1):222. doi: 10.1038/s41392-020-00317-1.

Manish Muhuri^{1

2}, Guangping Gao^{3

4

5}

¹ Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, USA.
² Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA, USA.
³ Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, USA. guangping.gao@umassmed.edu.
⁴ Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA, USA. guangping.gao@umassmed.edu.
⁵ Li Weibo Institute for Rare Diseases Research, University of Massachusetts Medical School, Worcester, MA, USA. guangping.gao@umassmed.edu.

No abstract available

Publication types